CDC Panel Recommends Preventive RSV Therapy for Babies

The US Centers for Disease Control and Prevention (CDC) said its advisory panel on Thursday recommended use of Sanofi and partner AstraZeneca's antibody therapy to prevent respiratory syncytial virus (RSV) in infants and toddlers.

Related Keywords

Bengaluru ,Karnataka ,India ,Mrinmay Dey ,Reuters ,Astrazeneca ,Drug Administration ,Us Centers For Disease ,Advisory Committee On Immunization Practices ,Disease Control ,Advisory Committee ,Immunization Practices ,Mariam Sunny ,Respiratory Syncytial Virus Infection ,Centers For Disease Control And Prevention Cdc ,Children ,Child ,Childhood ,Ediatrics ,Kids ,Immunizations ,Vaccination ,Newborn ,Neonate ,Respiratory Tract ,